Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression

References

• Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 2004;40:1387–95.
   PubMed Web of Science ®Google Scholar
• Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int 2006;26:856–63.
   PubMed Web of Science ®Google Scholar
• Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005;42:44–52.
   PubMed Web of Science ®Google Scholar
• Fan JG, Zhu J, Li XJ, Chen L, Lu YS, Li L, Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol 2005;20:1825–32.
   PubMed Web of Science ®Google Scholar
• Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y, Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 2005;22:1141–5.
   PubMed Web of Science ®Google Scholar
• Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221–31.
   PubMed Web of Science ®Google Scholar
• Brunt E, Janney C, Di Bisceglie A, Neuschwander-Tetri B, Bacon B. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467–74.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313–21.
   PubMed Web of Science ®Google Scholar
• Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA; NASH Clinical Research Network (CRN). Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 2011;53:810–20.
   PubMed Web of Science ®Google Scholar
• Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865–73.
   PubMed Web of Science ®Google Scholar
• Searle S, Haliday J, Powell L. Iron storage disease. In: MacSween R, Anthony P, Scheuer P, Burt A, Portman B, editors. Pathology of the Liver. Edinburgh: Churchill Livingston; 1994. pp 219–41.
   Google Scholar
• Neuschwander-Tetri B, Caldwell S. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202–19.
   PubMed Web of Science ®Google Scholar
• Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402–10.
   PubMed Web of Science ®Google Scholar
• Fassio E, Alvarez E, Domínguez N, Landeira G, Longo C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 2004;40:820–6.
   PubMed Web of Science ®Google Scholar
• Harrison S, Torgerson S, Hayashi P. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003;98:2042–7.
   PubMed Web of Science ®Google Scholar
• Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129:113–21.
   PubMed Web of Science ®Google Scholar
• Wieckowska A, Zein N, Yerian L, Lopez A, McCullough A, Feldstein A. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 2006;44:27–33.
   PubMed Web of Science ®Google Scholar
• Krasnoff J, Painter P, Wallace J, Bass N, Merriman R. Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. Hepatology 2008;47:1158–66.
   PubMed Web of Science ®Google Scholar
• Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 2006;355:2297–307.
   PubMed Web of Science ®Google Scholar
• Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA. Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial. Hepatology 2009;49:80–6.
   PubMed Web of Science ®Google Scholar
• Söderberg C, Stål P, Askling J, Glaumann H, Lindberg G, Marmur J, Hultcrantz R. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010;51:595–602.
   PubMed Web of Science ®Google Scholar
• de Oliveira C, de Mello E, Alves V, Saviero S, Strauss E. Changes in histological criteria lead to different prevalences of nonalcoholic steatohepatitis in severe obesity. Ann Hepatol 2007;6:255–61.
   PubMed Web of Science ®Google Scholar
• Matteoni C, Younossi Z, Gramlich T, Boparai N, Liu Y, McCullough A. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413–19.
   PubMed Web of Science ®Google Scholar
• Machado MV, Costa A, Coutinho J, Carepa F, Alves N, Cortez-Pinto H. Histological definitions of nonalcoholic steato hepatitis in a cohort of morbidly obese patients submitted to bariatric surgery: comparison of two classifications nad metabolic correlates [Abstract]. J Hepatol 2008;48(Suppl 2):S354.
   Google Scholar
• Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, Heller T, A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 2004;39:188–96.
   PubMed Web of Science ®Google Scholar
• Angulo P, Keach J, Batts K, Lindor K. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356–62.
   PubMed Web of Science ®Google Scholar
• Dixon J, Bhathal P, O'Brien P. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91–100.
   PubMed Web of Science ®Google Scholar
• Friedman S. Liver fibrosis–from bench to bedside. J Hepatol 2003;38(Suppl 1):S38–53.
   PubMed Web of Science ®Google Scholar
• Merriman RB, Ferrell LD, Patti MG, Weston SR, Pabst MS, Aouizerat BE, Bass NM. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006;44:874–80.
   PubMed Web of Science ®Google Scholar
• Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005;128:1898–906.
   PubMed Web of Science ®Google Scholar